Table 3. Timing of sera collection, neutralizing antibodies titers and clinical outcomes from 11 patients with clinically apparent H5N1 virus infection, 2003/2004.

# sera	Timing of collection (days post onset)	Antibody titers measured by MN* and H5pp*	Outcome	Patient identifier in references
				[26]	[12]
Cl 1	9	138–5	survived	Patient 5	Patient 6
	12	135–57
	13	100–208
	21	501–850
	31	1259–1055
	77	1995–2488
	203	537–1174
Cl 4	6	1–1	died	Patient 7	n/a
	10	50–7
	13	32–40
	17	1–29
Cl 17	5	45–6	died	Patient 8	n/a
Cl 26	6	1–12	survived	Patient 10	Patient 7
	18	5012–10169
	28	1413–2323
	68	537–2465
	188	316–624
	420	224–995
	421	224–219
	551	224–409
Cl 36	12	891–753	survived	n/a	Patient 8
	15	7943–5475
	25	1259–4978
	33	759–3873
	45	631–565
	59	166–473
	95	398–1892
	246	251–461
	400	112–851
	760	224–282
	773	72–201
Cl 100	19	112–863	died	n/a	Patient 3
Cl 101	6	17–54	died	n/a	n/a
Cl 107	7	40–165	died	n/a	Patient 4
	10	158–199
	11	63–255
Cl 112	9	122–226	died	n/a	n/a
Cl 114	10	200–34	survived	n/a	n/a
	80	126–527
Cl 115	5	32–47	survived	n/a	Patient 5
	116	158–133
	268	126–262
	416	126–650
	429	224–821
	444	158–331

*MN =  standard microneutralization test; *H5pp =  pseudotyped H5 particles-based microneutralization test.